Advancements in Chemical Biology: Targeting Thyroid Gland Function and Disease through Novel Therapeutic Approaches
Downloads
The thyroid gland plays a crucial role in regulating metabolism, yet its dysfunction leads to various endocrine disorders, including hypothyroidism and hyperthyroidism. While traditional therapeutic approaches focus on hormone replacement and surgical interventions, emerging advancements in chemical biology offer novel strategies for targeted treatment. This study explores the application of molecular and cellular techniques in enhancing thyroid disease diagnosis and therapy. A qualitative review of recent chemical biology research and clinical trials was conducted, highlighting innovative approaches such as synthetic biological tools, protein-ligand interactions, and nanotechnology-based drug delivery. Findings reveal that these advancements improve treatment specificity, minimize side effects, and provide new avenues for personalized medicine. The results suggest that interdisciplinary collaboration and continued research into chemical biology methodologies can lead to more effective and less invasive treatments for thyroid disorders. This study emphasizes the need for integrating chemical biology innovations into standard thyroid disease management.
M. J. C. Long, X. Liu, and Y. Aye, "Chemical Biology Gateways to Mapping Location, Association, and Pathway Responsivity," 2019. [PDF]
M. J. C. Long, X. Liu, and Y. Aye, "Chemical Biology Gateways to Mapping Location, Association, and Pathway Responsivity," 2019. ncbi.nlm.nih.gov
Y. C. Liu, C. T. Yeh, and K. H. Lin, "Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis," 2019. ncbi.nlm.nih.gov
T. Huyck and M. Agulnik, "Molecular Therapies in Thyroid Cancer," 2010. ncbi.nlm.nih.gov
R. Agrawal and S. Ahmad, "Graves' Disease: Novel Diagnostic Approaches and Emerging Treatment Options," 2025. intechopen.com
L. Aversano, M. L. Bernardi, and M. Cimitile, "Thyroid disease treatment prediction with machine learning approaches," Procedia Computer, Elsevier, 2021. sciencedirect.com
H. B. Burch, P. Perros, T. Bednarczuk, "Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association," European thyroid, 2022. bioscientifica.com
S. Benvenga, "L-T4 Therapy in the Presence of Pharmacological Interferents," 2020. ncbi.nlm.nih.gov
H. Zherka Saracini, "Surgical Treatment of Thyroid Gland Our experience of three years in DCVS," 2015. [PDF]
D. Cayir and M. Araz, "Radioiodine Therapy of Benign Thyroid Diseases," 2017. [PDF]
C. Sparano, S. Moog, J. Hadoux, C. Dupuy, and A. Al Ghuzlan, "Strategies for radioiodine treatment: what's new," *Cancers*, 2022. mdpi.com
W. Zhang and J. A. Catanzaro, "Individualized Therapeutic Design in Thyroid Disease: Strategies Through Genetic, Molecular, and Technological Innovations," Journal of Precision, 2022. emanresearch.org
S. Al Qammaz, "Radioiodine treatment of hyper-functioning thyroid-the effect of adjusted calculation methods on therapy and disease outcome," 2023. lsmu.lt
M. A. Kowalik, A. Columbano, and A. Perra, "Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease," 2018. ncbi.nlm.nih.gov
D. Laha, N. Nilubol, and M. Boufraqech, "New Therapies for Advanced Thyroid Cancer," 2020. ncbi.nlm.nih.gov
Y. F. Yang, B. Yu, X. X. Zhang, and Y. H. Zhu, "Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction," 2021. ncbi.nlm.nih.gov
M. C. Anania, F. Gasparri, E. Cetti, I. Fraietta et al., "Identification of thyroid tumor cell vulnerabilities through a siRNA-based functional screening," 2015. [PDF]
L. Shapiro-Kulnane, O. Bautista, and H. K. Salz, "An RNA-interference screen in Drosophila to identify ZAD-containing C2H2 zinc finger genes that function in female germ cells," G3, 2021. oup.com
B. R. da Cunha, P. Zoio, L. P. Fonseca, and C. R. C. Calado, "Technologies for high-throughput identification of antibiotic mechanism of action," Antibiotics, 2021. mdpi.com
C. H. Lee, H. C. Huang, and H. F. Juan, "Reviewing Ligand-Based Rational Drug Design: The Search for an ATP Synthase Inhibitor," 2011. ncbi.nlm.nih.gov
D. Delcassian, A. K. Patel, A. B. Cortinas, and R. Langer, "Drug delivery across length scales," 2019. [PDF]
K. Wang, Y. Zhang, Y. Xing, H. Wang et al., "Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials," 2024. ncbi.nlm.nih.gov
J. Salazar, T. Carmona, F. C. Zacconi, and D. Venegas-Yazigi, "The human dermis as a target of nanoparticles for treating skin conditions," Pharmaceutics, 2022. mdpi.com
ZF Liu, CY Chew, S Honavar, A Maxwell, "Seeing beyond skin deep: high‐resolution ultrasound in dermatology—a comprehensive review and future prospects," *Journal of the …*, 2024. [HTML]
A. Antonelli, P. Fallahi, S. M Ferrari, I. Ruffilli et al., "New Targeted Therapies for Thyroid Cancer," 2011. ncbi.nlm.nih.gov
H. E Yazdaan, F. Jaya, F. Sanjna, M. Junaid et al., "Advances in Thyroid Function Tests: Precision Diagnostics and Clinical Implications," 2023. ncbi.nlm.nih.gov
S. Visvikis-Siest, D. Theodoridou, M. S. Kontoe, S. Kumar et al., "Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-19," 2020. ncbi.nlm.nih.gov
D. Peer, "Theranostic nanoparticles for treatment of inflammatory disease and cancer," 2016. [PDF]
